The reaction of 4-iodobenzenesulfonamide or 4-fluorobenzenesulfonamide with CS 2 and KOH in dimethylformamide yielded the potassium N-R-sulfonyldithiocarbimates, K 2 (RSO 2 N@CS 2) [R = 4-IC 6 H 4 (1) and 4-FC 6 H 4 (2)]. These salts reacted with K 2 [PtCl 4 ] in water/methanol to yield complex anions bis(N-R-sulfonyldithiocarbimato)platinate(II), which were isolated as their tetrabutylammonium salts, (Bu 4 N) 2 [Pt(RSO 2 N@CS 2) 2 ] [R = 4-IC 6 H 4 (3) and 4-FC 6 H 4 (4)]. The structures of 2-4 were determined by X-ray crystallography. The Pt 2+ in both complexes 3 and 4 lies at the inversion centre and the PtS 4 moiety has a distorted square-planar configuration. The compounds were also characterized by IR, 1 H NMR and 13 C NMR spectroscopies, and elemental analyses. The molar conductance data are consistent with the fact that 3 and 4 are dianionic complexes.
Two new zinc(II)-complexes, dithiocarbimato (Ph 4 P) 2 [Zn(CH 3 SO 2 N@CS 2) 2 ] (1) and trithiocarbimato (Ph 4 P) 2 [Zn(CH 3 SO 2 N@CS 3) 2 ] (2), were obtained in the crystalline form by the reaction of potassium N-methylsulfonyldithiocarbimate (RSO 2 N@CS 2 K 2) with zinc(II) acetate dihydrate and tetraphenylphosphonium chloride in dimethylformamide. Both complexes crystallize in the monoclinic system. The central Zn(II) ion has a distorted tetrahedral coordination in both compounds. In 1 the dithiocarbimato ligand coordinates via two S atoms while in 2 the trithiocarbimato ligand coordinates via S and N atoms. Both complexes were also characterized by IR, 1 H NMR and 13 C NMR spectroscopies. Compound 2 is the first example of a zinc(II)-trithiocarbimato complex.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.